Skip to main content
. 2012 May 8;17(5):5422–5429. doi: 10.3390/molecules17055422

Table 2.

Cytotoxicity (IC50 μg/mL) of compounds 1 and 2.

Cell Lines
Compound HL60 MDA-MB-231 DLD-1 HCT-116
1 NA b NA b NA b NA b
2 NA b NA b NA b NA b
Doxorubicin a 0.058 6.31 5.71 0.51

a Clinical anticancer drug used as a positive control. b NA, not active at 20 μg/mL.